There was indeed a clear-cut variation in the pattern of gene-specific promoter CpG methylation status of STAT1, STAT6, IL12b, MHC2, iNOS, SOCS5, JAK1 and JAK2 between CAD patients versus healthy controls. The gene discussed is JAK2; the disease is coronary artery disorder.